Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
Wall Street
Price Targets
LINCOLN Price Targets Summary
Lincoln Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for
LINCOLN
is 1 028.16 INR
with a low forecast of 1 018.08 INR and a high forecast of 1 058.4 INR.
Operating Income
Forecast
Operating Income Estimate
Lincoln Pharmaceuticals Ltd
For the last 8 years the
compound annual growth rate for
Lincoln Pharmaceuticals Ltd's operating income is
12%.
The projected
CAGR
for the next 3 years is
19%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LINCOLN's stock price target?
Price Target
1 028.16
INR
According to Wall Street analysts, the average 1-year price target for
LINCOLN
is 1 028.16 INR
with a low forecast of 1 018.08 INR and a high forecast of 1 058.4 INR.
What is Lincoln Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
Lincoln Pharmaceuticals Ltd's revenue is
5%.
The projected
CAGR
for the next 3 years is
16%.
What is Lincoln Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
19%
For the last 8 years the
compound annual growth rate for
Lincoln Pharmaceuticals Ltd's operating income is
12%.
The projected
CAGR
for the next 3 years is
19%.
What is Lincoln Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
Lincoln Pharmaceuticals Ltd's net income is
19%.
The projected
CAGR
for the next 3 years is
16%.
You don't have any saved screeners yet
